FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 251 through 271 of 271

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
VALN Nasdaq Valneva SE 2830
VCYT Nasdaq Veracyte, Inc. 2830
VERA Nasdaq Vera Therapeutics, Inc. 2830
VFF Nasdaq Village Farms International, Inc. 2830
VIR Nasdaq Vir Biotechnology, Inc. 2830
VRCA Nasdaq Verrica Pharmaceuticals Inc. 2830
VRDN Nasdaq Viridian Therapeutics, Inc. 2830
WVE Nasdaq Wave Life Sciences, Inc. 2830
WXXWY Over the counter WuXi Biologics (Cayman) Inc. 2830
XBIT Nasdaq XBiotech Inc. 2830
XCUR Nasdaq Exicure, Inc. 2830
XERS Nasdaq Xeris Biopharma Holdings, Inc. 2830
XFOR Nasdaq X4 Pharmaceuticals, Inc. 2830
XRTX Nasdaq XORTX Therapeutics Inc. 2830
XTLB Nasdaq XTL Biopharmaceuticals Ltd. 2830
YCBD NYSE American cbdMD, Inc. 2830
ZEOX Over the counter Zeo ScientifiX, Inc. 2830
ZLDPY Over the counter Zealand Pharma A/S 2830
ZTS New York Zoetis Inc. 2830
ZVRA Nasdaq Zevra Therapeutics, Inc. 2830
ZYBT Nasdaq Zhengye Biotechnology Holding Limited 2830
Results 250 through 271 of 271